Jesica Ramirez-Santos

Dr. Jesica Ramirez-Santos

Instituto Politécnico Nacional Escuela Superior de Medicina, Mexico City, Ciudad de México, Mexico
+1
orcid
Unidad de Investigación Médica en Farmacología. IMSS Siglo X...

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Jesica Ramirez-SantosJesica Ramirez-Santos
Jesica Ramirez-Santos
Fernando CalzadaFernando Calzada
Fernando Calzada
Normand García-HernándezNormand García-Hernández
Normand García-Hernández
EBELIZABETH BARBOSA
ELIZABETH BARBOSA
CGClaudia Velázquez González
Claudia Velázquez González
Miguel ValdesMiguel Valdes
Miguel Valdes
The Annona genus contains some species used in Mexican traditional medicine for the treatment cancer, including Annona macroprophyllata (A. macroprophyllata). The present study aimed to investigate the anticancer activity of caryophyllene oxide (CO) isolated from A. macroprophyllata using in vivo, in vitro, and in silico approaches. The identification of CO was performed using gas chromatography-mass spectroscopy and NMR methods. Antilymphoma activity was evaluated in male and female Balb/c mice inoculated with U-937 cells. Cytotoxic activity was evaluated using the WST method and flow cytometry was used to determine the type of cell death. Acute oral toxicity was determined, and a molecular docking study was performed using target proteins associated with cancer, including, HMG-CoA, Bcl-2, Mcl-1, and VEGFR-2. Results showed that CO exhibited significant antilymphoma and cytotoxic activities, and its effects were comparable to MTX. In addition, flow cytometry showed that the anticancer activity of CO could be mediated by the induction of late apoptosis and necrosis. The result for the acute oral toxicity of CO was classified in category 4, suggesting it is low risk. Finally, molecular coupling studies showed that CO had more affinity for the enzymes HMG-CoA reductase and Bcl-2. Our study provides evidences that CO is a potential anticancer agent for the treatment of histiocytic lymphoma.

21 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Jesica Ramirez-SantosJesica Ramirez-Santos
Jesica Ramirez-Santos
Fernando CalzadaFernando Calzada
Fernando Calzada
JMJessica Elena Mendieta-Wejebe
Jessica Elena Mendieta-Wejebe
Rosa María Ordoñez-RazoRosa María Ordoñez-Razo
Rosa María Ordoñez-Razo
RMRubria Marlen Martínez-Casares
Rubria Marlen Martínez-Casares
Miguel ValdesMiguel Valdes
Miguel Valdes
Annona macroprophyllata Donn (A. macroprophyllata) is used in traditional Mexican medicine for the treatment of cancer, diabetes, inflammation, and pain. In this work, we evaluated the antitumor activity of three acyclic terpenoids obtained from A. macroprophyllata to assess their potential as antilymphoma agents. We identified the terpenoids farnesyl acetate (FA), phytol (PT) and geranylgeraniol (Gg) using gas chromatography–mass spectroscopy (GC-MS) and spectroscopic (1H, and 13C NMR) methods applied to petroleum ether extract of leaves from A. macroprophyllata (PEAm). We investigated antitumor potential in Balb/c mice inoculated with U-937 cells by assessing brine shrimp lethality (BSL), and cytotoxic activity in these cells. In addition, to assess the potential toxicity of PEAm, FA, PT and Gg in humans, we tested their acute oral toxicity in mice. Our results showed that the three terpenoids exhibited considerable antilymphoma and cytotoxic activity. In terms of lethality, we determined a median lethal dose (LD50) for thirteen isolated products of PEAm. Gg, PT and AF all exhibited a higher lethality with values of 1.41 ± 0.42, 3.03 ± 0.33 and 5.82 ± 0.58 µg mL−1, respectively. To assess cytotoxic activity against U-937 cells, we calculated the mean cytotoxic concentration (CC50) and found that FA and PT were closer in respect to the control drug methotrexate (MTX, 0.243 ± 0.007 µM). In terms of antilymphoma activity, we found that FA, PT and Gg considerably inhibited lymph node growth, with median effective doses (ED50) of 5.89 ± 0.39, 6.71 ± 0.31 and 7.22 ± 0.51 mg kg−1 in females and 5.09 ± 0.66, 5.83 ± 0.50 and 6.98 ± 0.57mg kg −1 in males, respectively. Regarding acute oral toxicity, we classified all three terpenoids as category IV, indicating a high safety margin for human administration. Finally, in a molecular docking study of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, we found binding of terpenoids to some amino acids of the catalytic site, suggesting an effect upon activity with a resulting decrease in the synthesis of intermediates involved in the prenylation of proteins involved in cancer progression. Our findings suggest that the acyclic terpenoids FA, PT, and Gg may serve as scaffolds for the development of new treatments for non-Hodgkin’s lymphoma.

7 March 2020 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Closed access
PDF file
Fernando CalzadaFernando Calzada
Fernando Calzada
Jesica Ramirez-SantosJesica Ramirez-Santos
Jesica Ramirez-Santos
Miguel ValdesMiguel Valdes
Miguel Valdes
Normand García-HernándezNormand García-Hernández
Normand García-Hernández
EPEmmanuel Pina-Jiménez
Emmanuel Pina-Jiménez
Rosa María Ordoñez-RazoRosa María Ordoñez-Razo
Rosa María Ordoñez-Razo

Verified
Journal Article
Open access
PDF file
Fernando CalzadaFernando Calzada
Fernando Calzada
Jesica Ramirez-SantosJesica Ramirez-Santos
Jesica Ramirez-Santos
Rosa María Ordoñez-RazoRosa María Ordoñez-Razo
Rosa María Ordoñez-Razo
Miguel ValdesMiguel Valdes
Miguel Valdes
CGClaudia Velázquez González
Claudia Velázquez González
EBELIZABETH BARBOSA
ELIZABETH BARBOSA
Terpenoids are a large group of molecules present in several plant species and in many essential oils reported with cytotoxic and anticancer properties. The aim of this study was to evaluate the anticancer activity of eleven acyclic terpenes; seven monoterpenoids: geranyl acetate (C1), geranic acid (C2), citral (C3, mixture of neral and geranial), geraniol (C4), methyl geranate (C5), nerol (C6) and citronellic acid (C7); two sesquiterpenes: farnesal (C8) and farnesol (C9); and one triterpene: squalene (C10), using in vivo, in vitro, and in silico models. Anti-lymphoma activity was evaluated using male Balb/c mice inoculated with U-937 cells. Cytotoxic activity was evaluated using the WST-1 method. Computer tools were used to obtain a molecular docking study, measuring pharmacokinetic and toxicological properties of the acyclic terpenoids with greater antitumor activity. The results showed that the terpenoids with the highest cytotoxic and nodal growth inhibitory activity were C3, C4, C6, and C9, and their effects were better compared to MTX. The data obtained suggest that the anti-lymphoma activity could be due to the presence of the aldehyde, hydroxyl, and acetate groups in the C1 of the monoterpenes and sesquiterpenes evaluated. The theoretical results obtained from molecular docking showed that geranial (C3A), neral (C3B), C9, and C6 terpenoids obtained a higher affinity for the HMG-CoA reductase enzyme and suggest that it could be a target to induce anti-lymphoma activity of bioactive terpenoids. Our study provides evidence that C3, C6, and C9 could be potential anticancer agents for the treatment of histiocytic lymphoma.

24 April 2024 in Molecules
Verified
Journal Article
Open access
PDF file
Jesica Ramirez-SantosJesica Ramirez-Santos
Jesica Ramirez-Santos
Fernando CalzadaFernando Calzada
Fernando Calzada
Rosa María Ordoñez-RazoRosa María Ordoñez-Razo
Rosa María Ordoñez-Razo
JMJessica Elena Mendieta-Wejebe
Jessica Elena Mendieta-Wejebe
JDJose Antonio VELAZQUEZ DOMINGUEZ
Jose Antonio VELAZQUEZ DOMINGUEZ
EBELIZABETH BARBOSA
ELIZABETH BARBOSA
Ilama leaves are an important source of secondary metabolites with promising anticancer properties. Cancer is a disease that affects a great number of people worldwide. This work aimed to investigate the in vivo, in vitro and in silico anticancer properties of three acyclic terpenoids (geranylgeraniol, phytol and farnesyl acetate) isolated from petroleum ether extract of ilama leaves. Their cytotoxic activity against U-937 cells was assessed using flow cytometry to determine the type of cell death and production of reactive oxygen species (ROS). Also, a morphological analysis of the lymph nodes and a molecular docking study using three proteins related with cancer as targets, namely, Bcl-2, Mcl-1 and VEGFR-2, were performed. The flow cytometry and histomorphological analysis revealed that geranylgeraniol, phytol and farnesyl acetate induced the death of U-937 cells by late apoptosis and necrosis. Geranylgeraniol and phytol induced a significant increase in ROS production. The molecular docking studies showed that geranylgeraniol had more affinity for Bcl-2 and VEGFR-2. In the case of farnesyl acetate, it showed the best affinity for Mcl-1. This study provides information that supports the anticancer potential of geranylgeraniol, phytol and farnesyl acetate as compounds for the treatment of cancer, particularly with the potential to treat non-Hodgkin’s lymphoma.

18 November 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Jesica Ramirez-SantosJesica Ramirez-Santos
Jesica Ramirez-Santos
Fernando CalzadaFernando Calzada
Fernando Calzada
Julita MartÍnez-RodríguezJulita MartÍnez-Rodríguez
Julita MartÍnez-Rodríguez
Miguel ValdesMiguel Valdes
Miguel Valdes
EBELIZABETH BARBOSA
ELIZABETH BARBOSA
CGClaudia Velázquez González
Claudia Velázquez González
Background: Annona cherimola Miller (A. cherimola) is traditionally used in Mexico to treat diabetes. Objectives: this study aimed to evaluate the antihyperglycemic activity of the aqueous leaf extracts (AEAcL) and stem (AEAcS) of A. cherimola alone and combined with oral antidiabetic drugs (OADs), as well as to determine their effect on % HbA1c, lipid parameters and toxicity. As well, the study aimed to isolate and identify some of its compounds to propose findings about its mode of action. Methods: Antihyperglycemic activity was evaluated using in vivo models with streptozotocin-induced experimental diabetes in Balb/c mice. Computer tools were used to obtain the pharmacokinetic and toxicological properties of the identified flavonoids; to obtain findings on their potential as α-glucosidase and SGLT1 inhibitors, in vivo and in silico studies were carried out using oral sucrose tolerance (OSTT) and glucose (OGTT) tests and molecular coupling studies. Results: ÇAEs and aSAAcS administered alone at 200 mg/kg showed a significant reduction in hyperglycemia. The best combination was AEAcL + Met (100/500 mg/kg), which significantly reduced hyperglycemic values and the % of HbA1c, TG, and LDL. The flavonoids isolated from AEAcL were identified as rutin, nicotiflorin, and narcissin. The molecular coupling assay and OSTT and OGTT tests showed that the flavonoids could inhibit α-glucosidase and SGLT1. Conclusions: AEAcL shows significant antihyperglycemic and antihyperlipidemic activity in murine models of diabetes, both alone (100 mg/kg) and in combination with metformin (100/500 mg/kg). Isolated flavonoids (rutin, nicotiflorin, and narcissine) appear to be partly responsible for these effects, although they have pharmacokinetic limitations. In silico and in vivo studies suggest a possible mechanism of action by inhibition of α-glucosidase and SGLT1.